Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
entrez:
29
2
2020
pubmed:
29
2
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Breast cancer is the most frequent cancer in women, and there is a great variability in surgical practice for treating that cancer in different countries. The aims of this study were to analyze the effect of guidelines from the Turkish Federation of Breast Diseases Societies on academic institutions that have breast centers and to evaluate surgical practice in Turkey in 2018. Between January and March 2019, a survey was sent to breast surgeons who were working in breast centers in academic institutions. The sampling frame included 24 academic institutions with breast centers in 18 cities in Turkey to evaluate interdisciplinary differences among breast centers and seven regions in Turkey regarding patients' choices, surgical approaches, and academic institutions. All surgeons responded to the survey, and all 4,381 patients were included. Most of the surgeons (73.9%) were working in a breast center. Multidisciplinary tumor boards were performed in 87% of the breast centers. The average time between clinical evaluation and initiation of treatment was 29 days; the longest time was in Southeast Anatolia (66 days). Only 6% of patients had ductal carcinoma in situ. Sentinel lymph node biopsy was available in every region across the country and was performed in 64.5% of the patients. In 2018, the overall breast-conserving surgery rate was 57.3% in Turkey, and it varied from 72.2% in the Black Sea region to 33.5% in Central Anatolia ( Increasing rates of nonpalpable breast cancer and decreasing rates of locoregional recurrences favored breast-conserving surgery, especially in developed countries. Guidelines from the Turkish Federation of Breast Diseases Societies resulted in more comprehensive breast centers and improved breast health in Turkey.
Identifiants
pubmed: 32109157
doi: 10.1200/JGO.19.00275
pmc: PMC7051798
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-292Références
Eur J Public Health. 2015 Feb;25(1):9-14
pubmed: 25096257
Eur J Breast Health. 2019 Jul 01;15(3):141-146
pubmed: 31312788
Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S36-43
pubmed: 20620013
Lancet Oncol. 2014 Nov;15(12):1303-10
pubmed: 25439688
Lancet. 2013 Sep 28;382(9898):1121-9
pubmed: 24075052
BMC Cancer. 2011 Apr 19;11:145
pubmed: 21504577
Ann Surg Oncol. 2018 Oct;25(10):2807-2812
pubmed: 29968033
BMJ. 2012 Apr 26;344:e2718
pubmed: 22539013
JAMA Surg. 2013 Oct;148(10):971-9
pubmed: 23986370
J Breast Health. 2014 Apr 1;10(2):98-105
pubmed: 28331652
Am J Surg. 2020 Jan;219(1):211-212
pubmed: 31010577
N Engl J Med. 1992 Apr 23;326(17):1102-7
pubmed: 1552911
N Engl J Med. 2002 Oct 17;347(16):1227-32
pubmed: 12393819
Eur J Surg Oncol. 2019 Apr;45(4):567-572
pubmed: 30638809
Ann Surg. 2013 Nov;258(5):808-13; discussion 813-4
pubmed: 23989053
Ann Surg Oncol. 2010 May;17(5):1375-91
pubmed: 20140531
JAMA. 2011 Feb 9;305(6):569-75
pubmed: 21304082
Breast Cancer Res Treat. 2019 Jan;173(2):267-274
pubmed: 30361873
Ann Surg Oncol. 2008 Feb;15(2):443-51
pubmed: 17909915
Nature. 2015 Nov 19;527(7578):S102-3
pubmed: 26580155
Eur J Surg Oncol. 2016 Jan;42(1):51-8
pubmed: 26490007
JAMA. 2018 May 1;319(17):1814-1815
pubmed: 29715344
Ann Oncol. 2019 Aug 1;30(8):1356-1369
pubmed: 31147719
Ann Plast Surg. 2014 Feb;72(2):145-9
pubmed: 23503430
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
N Engl J Med. 1992 Apr 23;326(17):1097-101
pubmed: 1552910
N Engl J Med. 1985 Mar 14;312(11):665-73
pubmed: 3883167
Lancet Oncol. 2010 Oct;11(10):927-33
pubmed: 20863759
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur J Cancer. 2001 Jan;37(1):83-92
pubmed: 11165134